CS-206 in Patients With Sickle Cell Disease

NCT06565026 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Disease

Interventions

GENETIC: CS-206

Sponsor

CorrectSequence Therapeutics Co., Ltd

Collaborators

[object Object]